ACTIVE

GSK-PROJECTEN

Financial year 2025 · Closed on 30/06/2025

Net result1,7 k €-93,5 %over 1 year

Gross margin12,4 k €-80,6 %over 1 year

Equity58,6 k €+3,1 %over 1 year

Identity

Source · BCE/KBO

GSK-PROJECTEN is a Private limited company incorporated in 2007. Its main activity is: Development of building projects. Its registered office is in Hasselt.

Legal situation: Normal situation
BCE/KBO no. / VAT: BE 0890.187.608
Incorporation: 31/05/2007
Legal form: Private limited company
Registered office: Guffenslaan 44
3500 Hasselt · FlandreSee on map
Contributed capital: 10 172,50 €
Latest accounts: 30/06/2025

Activities (NACE)

41101Development of building projects· main 68121Buying and selling of own real estate 70111Activities of head offices 41102Development of building projects 68100Buying and selling of own real estate 68110Buying and selling of own real estate+12

Signals

ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDA

Financials

Source · NBB, 17 filings

Trend over 17 financial years

	2025		2024		2023		2022		2021
Income statement
Gross margin	12,4 k €	-80.6%	63,7 k €	+174%	23,2 k €	-45.9%	42,9 k €	+89.7%	22,6 k €
EBITDA	11,4 k €	-82.0%	63,2 k €	+177%	22,8 k €	-43.8%	40,6 k €	+99.6%	20,3 k €
Operating result	9,6 k €	-84.5%	62,1 k €	+186%	21,7 k €	-45.1%	39,4 k €	+106%	19,2 k €
Net result	1,7 k €	-93.5%	26,7 k €	+208%	8,7 k €	-83.8%	53,6 k €	+119%	24,5 k €
Balance sheet
Equity	58,6 k €	+3.1%	56,9 k €	+3.1%	55,2 k €	+18.6%	46,5 k €	+67.0%	27,9 k €
Total assets	66,1 k €	-78.7%	310,5 k €	-19.4%	385,4 k €	+73.4%	222,3 k €	+22.5%	181,4 k €
Cash	7,6 k €	-97.0%	257,2 k €	+6312%	4 k €	+32.1%	3 k €	-51.7%	6,3 k €
Debts	7,5 k €	-97.1%	253,7 k €	-0.8%	255,6 k €	+45.4%	175,8 k €	+14.5%	153,6 k €

Valuation

Indicative valuation

As an indication, this company is worth

between 100 k€ and 250 k€

See the valuation

Board of directors

Source · NBB, accounts to 30/06/2025

1 active · 1 ended

Active mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
Gerard Schouten	Directorsince 05/07/2024Manager2020 accountsended

Ended mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
GSK-Beheer0871.717.917Represented by Gerard Schouten	Manager2021 accountsMandate2022 accountsDirector2023 accounts

Other companies at this address

Guffenslaan 44 3500 Hasselt

Company	CBE no.
BOUWID● Active	0833.021.152
BRIC architectuur● Active	1014.907.040
GSK-Beheer● Active	0871.717.917
GSK INVESTMENT COMPANY● Active	0883.242.111
TERRA NOVA● Active	1035.421.748

Full financial information

Source · NBB

	2025	2024	2023	2022	2021	2020
Type of account	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model
Start of the financial year	01/07/2024	01/07/2023	01/07/2022	01/07/2021	01/07/2020	01/07/2019
Closing of the financial year	30/06/2025	30/06/2024	30/06/2023	30/06/2022	30/06/2021	30/06/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	30/01/2026	09/01/2025	11/01/2024	26/12/2022	15/12/2021	30/12/2020
General meeting	12/12/2025	13/12/2024	08/12/2023	09/12/2022	10/12/2021	11/12/2020
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 17 filings

Model	Closing	General meeting	Filed	Language	Document
Abridged model	30/06/2025	12/12/2025	30/01/2026	Dutch	PDF
Abridged model	30/06/2024	13/12/2024	09/01/2025	Dutch	PDF
Abridged model	30/06/2023	08/12/2023	11/01/2024	Dutch	PDF
Abridged model	30/06/2022	09/12/2022	26/12/2022	Dutch	PDF
Abridged model	30/06/2021	10/12/2021	15/12/2021	Dutch	PDF
Abridged model	30/06/2020	11/12/2020	30/12/2020	Dutch	PDF
Abridged model	30/06/2019	13/12/2019	23/12/2019	Dutch	PDF
Abridged model	30/06/2018	14/12/2018	01/01/2019	Dutch	PDF
Abridged model	30/06/2017	08/12/2017	23/12/2017	Dutch	PDF
Abridged model	30/06/2016	09/12/2016	29/12/2016	Dutch	PDF
Abridged model	30/06/2015	11/12/2015	22/12/2015	Dutch	PDF
Abridged model	30/06/2014	12/12/2014	22/12/2014	Dutch	PDF
Abridged model	30/06/2013	13/12/2013	22/12/2013	Dutch	PDF
Abridged model	30/06/2012	14/12/2012	03/01/2013	Dutch	PDF
Abridged model	30/06/2011	09/12/2011	21/12/2011	Dutch	PDF
Abridged model	31/12/2009	11/06/2010	28/06/2010	Dutch	PDF
Abridged model	31/12/2008	12/06/2009	22/06/2009	Dutch	PDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 100 k€ and 250 k€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 30/06/2025

1 active · 1 ended

Active mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
Gerard Schouten	Directorsince 05/07/2024Manager2020 accountsended

Ended mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
GSK-Beheer0871.717.917Represented by Gerard Schouten	Manager2021 accountsMandate2022 accountsDirector2023 accounts

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette

Mandates06/08/2024
ONTSLAGEN - BENOEMINGEN
PDF
Mandates11/03/2024
STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - WIJZIGING RECHTSVORM - ONTSLAGEN - BENOEMINGEN
PDF
Mandates21/01/2021
ONTSLAGEN - BENOEMINGEN - WIJZIGING RECHTSVORM
PDF
Registered office19/02/2016
VERPLAATSING MAATSCHAPPELIJKE ZETEL
PDF
Mandates28/09/2011
ONTSLAGEN - BENOEMINGEN
PDF
Other27/12/2010
VERLEGGING BOEKJAAR
PDF
Registered office28/10/2009
ZETELVERPLAATSING
PDF
Other28/06/2007
OPRICHTING
PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

Source · CBE, NBB annual accounts

Year

Identity

Incorporation

Name

Registered office

Annual accounts

Filings17 filings

Mandates

Gerard Schouten

GSK-Beheer

20072008200920102011201220132014201520162017201820192020202120222023202420252026

GSK-PROJECTEN

Guffenslaan 44, 3500 Hasselt

Director

CurrentPlanned, not yet servedEndedAccounts filedToday

Registered offices

Source · NBB annual accounts, CBE

Registered address	Period	Source
Guffenslaan 44, 3500 HasseltCurrent	accounts 2022 → 2025	Accounts 2025 · 2026-00021143

Company names

Source · NBB annual accounts, CBE

Name	Period	Source
GSK-PROJECTENCurrent	accounts 2022 → 2025	Accounts 2025 · 2026-00021143

Events

2025
Annual accounts 20251,7 k €↓
2024
Annual accounts 202426,7 k €↑
2023
Annual accounts 20238,7 k €↓
2022
Annual accounts 202253,6 k €↑
2021
Annual accounts 202124,5 k €↑
2020
Annual accounts 202020,6 k €↓
2019
Annual accounts 201922,8 k €↑
2018
Annual accounts 201880,5 €↓
2017
Annual accounts 20177 k €↓
2016
Annual accounts 201671,4 k €↑
2015
Annual accounts 2015-7 k €↓
2014
Annual accounts 2014884,8 €↓
2013
Annual accounts 20132 k €↑
2012
Annual accounts 2012135,1 €↓
2011
Annual accounts 20115,2 k €↓
2009
Annual accounts 200920 k €↑
2008
Annual accounts 2008-27,3 k €
31/05/2007
IncorporationPrivate limited company

GSK-PROJECTEN

Overview

Identity

Financials

Valuation

Indicative valuation

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline

Timeline

Registered offices

Company names

Events